Stockreport

Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences [Financial Post (Toronto, Ontario, Canada)]

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF Author of the article: You can save this article by registering for free here . Or sign-in if you have an account. Felzartamab is an investigational anti-CD38 monoc [Read more]